Case number 1:23-cv-00331
Keryx Biopharmaceuticals, Inc. et al v. Zydus Worldwide DMCC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 6, 2023 | N/A | SO ORDERED, re 12 Stipulation of Dismissal filed by Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc., ***Civil Case Terminated. Signed by Judge Gregory B. Williams on 6/5/23. (ntl) (Entered: 06/06/2023) (0) |
| Jun 6, 2023 | 13 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 06/06/2023) (4) |
| Jun 2, 2023 | 12 | STIPULATION of Dismissal (without prejudice) - by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Raucci, Anthony) (Entered: 06/02/2023) (2) |
| Apr 11, 2023 | N/A | SO ORDERED, re 11 MOTION for Extension of Time to Respond to Complaint (Unopposed) filed by Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 4/11/23. (ntl) (Entered: 04/11/2023) (0) |
| Apr 6, 2023 | 8 | WAIVER OF SERVICE returned executed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.: For Zydus Lifesciences Limited waiver sent on 3/28/2023, answer due 5/30/2023. (Raucci, Anthony) (Entered: 04/06/2023) (1) |
| Apr 6, 2023 | 9 | WAIVER OF SERVICE returned executed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 3/28/2023, answer due 5/30/2023. (Raucci, Anthony) (Entered: 04/06/2023) (1) |
| Apr 6, 2023 | 10 | WAIVER OF SERVICE returned executed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.: For Zydus Worldwide DMCC waiver sent on 3/28/2023, answer due 5/30/2023. (Raucci, Anthony) (Entered: 04/06/2023) (1) |
| Apr 6, 2023 | 11 | MOTION for Extension of Time to Respond to Complaint (Unopposed) - filed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Raucci, Anthony) (Entered: 04/06/2023) (2) |
| Mar 29, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (nms) (Entered: 03/29/2023) (0) |
| Mar 27, 2023 | N/A | Remark: MDL Panel has been notified of case opening. (mpb) (Entered: 03/27/2023) (0) |
| Mar 24, 2023 | 1 | COMPLAINT filed against Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC ( Filing fee $ 402, receipt number ADEDC-4097120.) - filed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Attachments: # 1 Exhibits A-N, # 2 Civil Cover Sheet)(mpb) (Entered: 03/24/2023) (Main Document) (30) |
| Mar 24, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 03/24/2023) (3) |
| Mar 24, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/10/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/10/2025. (mpb) (Entered: 03/24/2023) (1) |
| Mar 24, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (mpb) (Entered: 03/24/2023) (2) |
| Mar 24, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Akebia Therapeutics, Inc. for Keryx Biopharmaceuticals, Inc. filed by Keryx Biopharmaceuticals, Inc.. (mpb) (Entered: 03/24/2023) (1) |
| Mar 24, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Panion & BF Biotech, Inc.. (mpb) (Entered: 03/24/2023) (1) |
| Mar 24, 2023 | 7 | Summons Issued as to Zydus Lifesciences Limited on 3/24/2023; Zydus Pharmaceuticals (USA) Inc. on 3/24/2023; Zydus Worldwide DMCC on 3/24/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mpb) (Entered: 03/24/2023) (Main Document) (2) |
| Mar 24, 2023 | 7 | Summons Issued as to Zydus Lifesciences Limited on 3/24/2023; Zydus Pharmaceuticals (USA) Inc. on 3/24/2023; Zydus Worldwide DMCC on 3/24/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mpb) (Entered: 03/24/2023) (Summons Issued) (2) |
| Mar 24, 2023 | 7 | Summons Issued as to Zydus Lifesciences Limited on 3/24/2023; Zydus Pharmaceuticals (USA) Inc. on 3/24/2023; Zydus Worldwide DMCC on 3/24/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mpb) (Entered: 03/24/2023) (Summons Issued) (2) |
| Mar 24, 2023 | 1 | COMPLAINT filed against Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC ( Filing fee $ 402, receipt number ADEDC-4097120.) - filed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Attachments: # 1 Exhibits A-N, # 2 Civil Cover Sheet)(mpb) (Entered: 03/24/2023) (Exhibit A-N) (30) |
| Mar 24, 2023 | 1 | COMPLAINT filed against Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC ( Filing fee $ 402, receipt number ADEDC-4097120.) - filed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Attachments: # 1 Exhibits A-N, # 2 Civil Cover Sheet)(mpb) (Entered: 03/24/2023) (Civil Cover Sheet) (2) |
